COVID-19 News

 

Immune Response Can Guide COVID-19 Treatment

MeMed's Technology May Help to Predict the Deterioration of
COVID-19 Patients (Hebrew)

Meet the Israeli Tech Companies Fighting COVID-19 Head-On

OurCrowd Portfolio Companies Pivot to Tackle Coronavirus Pandemic

 

MeMed to predict which COVID-19 patients will worsen

Media Coverage

Israeli firm advances diagnostic solutions for Covid-19

MeMed Receives CE Mark for Diagnostic Platform & Infection Assay

Test aiming to provide better treatment decisions receives

CE mark

MeMed Receives CE for Advanced Diagnostic Test

MeMed secures CE mark for new point of need blood test

MeMed Receives CE-IVD Mark for Infectious Disease Test

MeMed Ramping Up Commercialization Efforts Following Regulatory Approvals

Calcalist logo.png

MeMed Receives Regulatory Green Light for Test 

Study: MeMed's blood test distinguishes between bacterial, viral infections in children 

ISRAEL21C: Israel races to find solutions for coronavirus

World-Economic-Forum-Logo.png

MeMed Named "Technology Pioneer" by World Economic Forum

US DoD Commits Additional Funds to MeMed's Innovative Bacterial Versus Viral Test

The journey towards a disruptive blood test that can help address the threat of antibiotic resistance

Frost__Sullivan_Recognizes_MeMed-f62568d

Frost & Sullivan Recognizes MeMed with European Technology Leadership Award

Rapid blood test to 'cut antibiotic use'

FierceBiotechLogoNew.png

MeMed raises $70M for immune system-based infection diagnostics

Israeli Firm, US Department Of Defense To Fight Infectious Disease Together

MeMed Publishes New Data on Infectious Disease Dx, Plans 2018 Launch of POC Test

MeMed swiftly diagnoses if a disease is viral or bacterial 

Towards a world without antibiotics

Full story

(Hebrew)

globes_onLine-719158-58b8e7b65f9b58af5c9

MeMed raises $70M

New study shows MeMed's blood test accurately distinguishes bacterial and viral infections

Novel Assay Distinguishes Bacterial From Viral Infection in Kids

Infectious Disease Detective

MeMed Using $70M Funding Round to Develop Infection Test and POC Platform

The ultimate goal is to right-size antibiotic use

Israeli infection diagnostic start-up wins $9.2M funding boost

MeMed has received a contract from the Defense Threat Reduction Agency

MeMed Wins $4.1M DOD Grant toward Manufacturing of POC Platform

Viruses from Mars, bacteria from Venus

Podcast

(Hebrew)

MeMed Wins $9.2M DTRA Contract for PoC IVD to Reduce Antibiotic Misuse

MeMed Rolling Out Proteomic Test to Distinguish Between Bacterial, Viral Infections

A new blood test could stop doctors from over prescribing antibiotics

New Study Shows Superiority of MeMed's ImmunoXpert™ Over Procalcitonin, CRP, and HNL

MeMed has a rapid diagnostic that could help revolutionize the fight against drug-resistant bacteria

 

Press Releases

May 25, 2020

Oct 29, 2019

News 

 

March 29, 2020

March 25, 2020

Dec 5, 2018

ECCMID 2018 - 23/04/2018 09:00 am, Hall F

19 Apr, 2017

Listen to a podcast with Dr. Kfir Oved

Full list (Hebrew)

Dec 21, 2016

MeMed's CEO will talk about Opportunities and Challenges in Personalized Diagnostics at the annual IATI Biomed conference, on May 25, Tel-Aviv, Israel.

IATI Biomed 2016

MeMed will host a round table of leading European pediatricians at this year"s ESPID, to discuss new strategies of using host-response based diagnostics for reducing antibiotic misuse

ESPID 2016

MeMed Joins the CDC's Initiative for Addressing Antibiotic Resistance.

Nov 16, 2015

GLOBES (Hebrew)